CRDA: Other Outcomes (2023)

CRDA: Other Outcomes (2023)

• Intervention
  In adults with overweight or obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), what is the effect of carbohydrate (CHO) restriction compared to higher CHO diets on quality of life?

  • Conclusion

    Evidence suggests that intake of a moderate-carbohydrate (CHO) diet compared to a higher CHO intake may have no effect on quality of life in adults with overweight or obesity and metabolic dysfunction-associated steatotic liver disease (MASLD).

  • Grade: Very Low (D)
    • Grade I means there is Good/Strong evidence supporting the statement;
    • Grade II is Fair;
    • Grade III is Limited/Weak;
    • Grade IV is Expert Opinion Only;
    • Grade V is Not Assignable.
    • High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
    • Moderate (B) means we are moderately confident in the effect estimate;
    • Low (C) means our confidence in the effect estimate is limited;
    • Very Low (D) means we have very little confidence in the effect estimate.
    • Ungraded means a grade is not assignable.
  • Evidence Summary: In adults with overweight or obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), what is the effect of carbohydrate (CHO) restriction compared to higher CHO diets on quality of life?
    • Detail
    • Quality Rating Summary
      For a summary of the Quality Rating results, click here.
    • Worksheets
      • Properzi C, O'Sullivan T, Sherriff J, Ching H, Jeffrey G, Buckley R, Tibballs J, MacQuillan G, Garas G, Adams L. Ad Libitum Mediterranean and Low-Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial. Hepatology (Baltimore, MD) 2018; 68:1741-1754
  • Search Plan and Results: CRDA: Overweight or Obesity and MASLD 2023